Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tectonic Therapeutic (TECX) Other Operating Expenses (2017 - 2023)

Tectonic Therapeutic (TECX) has 2 years of Other Operating Expenses data on record, last reported at $83.7 million in Q2 2023.

  • On a quarterly basis, Other Operating Expenses changed N/A to $83.7 million in Q2 2023 year-over-year; TTM through Mar 2024 was $83.7 million, a N/A change, with the full-year FY2023 number at $83.7 million, changed N/A from a year prior.
  • Other Operating Expenses reached $83.7 million in Q2 2023 per TECX's latest filing, up from $14.2 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for TECX hit a ceiling of $83.7 million in Q2 2023 and a floor of $83.7 million in Q2 2023.